Talis Net Invested Capital vs Total Assets Analysis
TLIS Stock | USD 9.20 0.10 1.10% |
Talis Biomedical financial indicator trend analysis is much more than just breaking down Talis Biomedical Corp prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Talis Biomedical Corp is a good investment. Please check the relationship between Talis Biomedical Net Invested Capital and its Total Assets accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Talis Biomedical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
Net Invested Capital vs Total Assets
Net Invested Capital vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Talis Biomedical Corp Net Invested Capital account and Total Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Talis Biomedical's Net Invested Capital and Total Assets is 0.72. Overlapping area represents the amount of variation of Net Invested Capital that can explain the historical movement of Total Assets in the same time period over historical financial statements of Talis Biomedical Corp, assuming nothing else is changed. The correlation between historical values of Talis Biomedical's Net Invested Capital and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Invested Capital of Talis Biomedical Corp are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Net Invested Capital i.e., Talis Biomedical's Net Invested Capital and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.72 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Net Invested Capital
The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.Total Assets
Total assets refers to the total amount of Talis Biomedical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Talis Biomedical Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from Talis Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Talis Biomedical Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Talis Biomedical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Talis Biomedical's Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 0.75 in 2024, whereas Issuance Of Capital Stock is likely to drop 0.00 in 2024.
2019 | 2020 | 2023 | 2024 (projected) | Interest Income | 42K | 54K | 48.6K | 50.4K | Net Interest Income | 42K | 54K | 48.6K | 50.4K |
Talis Biomedical fundamental ratios Correlations
Click cells to compare fundamentals
Talis Biomedical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Talis Biomedical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 25.7M | 198.4M | 265.8M | 169.3M | 98.3M | 141.0M | |
Other Current Liab | 2.5M | 721K | 1.1M | 5.2M | 4.6M | 2.9M | |
Total Current Liabilities | 4.0M | 16.0M | 19.1M | 12.7M | 8.8M | 11.7M | |
Total Stockholder Equity | (21.1M) | (108.6M) | 234.0M | 126.7M | 69.1M | 45.5M | |
Net Tangible Assets | (21.1M) | (108.6M) | 234.0M | 126.7M | 145.7M | 153.0M | |
Property Plant And Equipment Net | 1.5M | 9.7M | 23.4M | 34.2M | 15.4M | 15.8M | |
Net Debt | (21.6M) | (137.8M) | (218.6M) | (96.6M) | (57.1M) | (59.9M) | |
Retained Earnings | (81.8M) | (172.9M) | (364.9M) | (478.0M) | (540.0M) | (513.0M) | |
Accounts Payable | 1.6M | 4.9M | 5.1M | 3.8M | 1.3M | 1.3M | |
Cash | 21.6M | 138.5M | 232.5M | 130.2M | 76.7M | 111.2M | |
Non Current Assets Total | 1.6M | 9.7M | 29.7M | 36.0M | 20.7M | 18.3M | |
Other Assets | 91K | 567K | 29.7M | 1.8M | 1.0 | 0.95 | |
Cash And Short Term Investments | 21.6M | 138.5M | 232.5M | 130.2M | 76.7M | 111.2M | |
Net Receivables | 1.8M | 471K | 183K | 308K | 50K | 47.5K | |
Common Stock Shares Outstanding | 3.6M | 290K | 1.5M | 1.8M | 1.8M | 1.5M | |
Liabilities And Stockholders Equity | 25.7M | 198.4M | 265.8M | 169.3M | 98.3M | 141.0M | |
Non Current Liabilities Total | 42.8M | 291.0M | 12.7M | 29.9M | 20.5M | 19.4M | |
Other Current Assets | 697K | 3.1M | 3.4M | 2.8M | 901K | 856.0K | |
Other Stockholder Equity | 17.9M | (226.6M) | 598.9M | 604.7M | 609.1M | 639.5M | |
Total Liab | 46.9M | 307.0M | 31.9M | 42.6M | 29.2M | 27.8M | |
Net Invested Capital | (21.1M) | (108.6M) | 234.0M | 126.7M | 69.1M | 45.5M | |
Property Plant And Equipment Gross | 1.5M | 9.1M | 23.4M | 34.2M | 28.4M | 18.1M | |
Total Current Assets | 24.1M | 188.7M | 236.1M | 133.3M | 77.7M | 122.7M | |
Net Working Capital | 20.1M | 172.7M | 217.0M | 120.6M | 68.9M | 111.0M | |
Property Plant Equipment | 1.5M | 9.7M | 23.4M | 34.2M | 39.4M | 41.3M |
Pair Trading with Talis Biomedical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Talis Biomedical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will appreciate offsetting losses from the drop in the long position's value.Moving against Talis Stock
0.62 | FNA | Paragon 28 | PairCorr |
0.61 | TFX | Teleflex Incorporated | PairCorr |
0.6 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
0.58 | SSY | SunLink Health Systems | PairCorr |
0.51 | AHG | Akso Health Group | PairCorr |
The ability to find closely correlated positions to Talis Biomedical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Talis Biomedical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Talis Biomedical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Talis Biomedical Corp to buy it.
The correlation of Talis Biomedical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Talis Biomedical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Talis Biomedical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Talis Biomedical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Talis Biomedical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Talis Stock analysis
When running Talis Biomedical's price analysis, check to measure Talis Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talis Biomedical is operating at the current time. Most of Talis Biomedical's value examination focuses on studying past and present price action to predict the probability of Talis Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talis Biomedical's price. Additionally, you may evaluate how the addition of Talis Biomedical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Talis Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Talis Biomedical. If investors know Talis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Talis Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (31.08) | Revenue Per Share 0.543 | Quarterly Revenue Growth (0.94) | Return On Assets (0.34) | Return On Equity (0.69) |
The market value of Talis Biomedical Corp is measured differently than its book value, which is the value of Talis that is recorded on the company's balance sheet. Investors also form their own opinion of Talis Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Talis Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Talis Biomedical's market value can be influenced by many factors that don't directly affect Talis Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talis Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talis Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Talis Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.